Cytokinetics | CYTK - DEBITO





DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Amgen USD 54.6B 17M 2025-12
Arca Biopharma USD 0 0 2025-03
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 6.56B 275.1M 2026-03
Brainstorm Cell Therapeutics USD 1.2M 1.2M 2025-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Cytokinetics USD 1.29B 4.48M 2026-03
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Exelixis USD 169.54M 3.5M 2026-03
Geron USD 121.99M 76K 2025-12
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
Merck USD 49.34B 7.97B 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.73B 231M 2026-03
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12